Early settlement of term loan and convertible bond facility removes long term debt

Paris, France and Camberley, UK – 3 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it will settle all outstanding debt obligations with Harbert European Growth Capital (“HEGC”) and Vatel Capital SAS (“Vatel”). http://novacyt.com/wp-content/uploads/2020/06/Novacyt-Early-settlement-of-term-loan-03-06-20-ENGLISH.pdf

Visit Page

Coronavirus update Sales and regulatory update

Paris, France and Camberley, UK – 2 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update on its polymerase chain reaction (PCR) test for COVID-19, developed by Primerdesign, the Company’s molecular diagnostics division. http://novacyt.com/wp-content/uploads/2020/06/Novacyt-COVID-19-update-02-06-20-ENGLISH.pdf

Visit Page

Liquidity Agreement Monthly Update and Total Voting Rights

Paris, France and Camberley, UK – 1 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised in

Visit Page